CTCP Dược phẩm Tipharco
13,500 ₫
+4.65%today
Billions of dong; EPS in dong
| Figure | Q3/2024 | Q4/2024 | Q1/2025 | Q2/2025 | Q3/2025⚠ | Q4/2025 | Q1/2026 | Q2/2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 66 | 148 | 58 | 66 | 69+4% | 124-16% | 71+21% | 78+19% |
| Gross profit | 13 | 31 | 12 | 12 | 13 | 30 | 19 | 19 |
| Net profit to shareholders | 3 | 10 | 0.3 | 0.3 | 0.9-70% | 11+11% | 6+1628% | 7+2335% |
| EPS | 358 | 1,215 | 42 | 34 | 95 | 1,173 | 627 | 728 |
| Total assets | 353 | 337 | 321 | 276 | 276 | 280 | 273 | 293 |
| Equity | 176 | 186 | 186 | 187 | 188 | 199 | 205 | 212 |
Scored from reported figures and the price against fixed bands; hover a factor for its figure. A quick read, not investment advice.
Source: company financial statements, via CafeF. ✓ audited; ≈ estimated.
No notes yet.
No entries yet.
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
CafeF
Market data from DNSE. News headlines link to their publishers. Information only — not investment advice.